IGFBP6 and chronic myelogenous leukemia, BCR-ABL1 positive: Since our data showed that co-culture between HS-5 and LAMA-84 leads to an increase in the IGFBP-6 both mRNA and protein expression levels and that LAMA-84 cell viability was higher after IGFBP-6 and dasatinib treatment than in LAMA-84 with dasatinib alone, we propose that IGFBP-6 could be involved in CML cell lines’ resistance mechanisms rescuing them from apoptosis.